1. Home
  2. INMB vs BTMD Comparison

INMB vs BTMD Comparison

Compare INMB & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.39

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.61

Market Cap

46.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INMB
BTMD
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.9M
46.2M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
INMB
BTMD
Price
$2.39
$1.61
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$5.40
$2.83
AVG Volume (30 Days)
342.0K
301.8K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
11.85
722.22
EPS
N/A
N/A
Revenue
$50,000.00
$192,219,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
N/A
Revenue Growth
257.14
N/A
52 Week Low
$1.09
$1.27
52 Week High
$2.48
$3.61

Technical Indicators

Market Signals
Indicator
INMB
BTMD
Relative Strength Index (RSI) 71.42 N/A
Support Level $1.37 N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.13 0.00
MACD 0.03 0.00
Stochastic Oscillator 87.50 0.00

Price Performance

Historical Comparison
INMB
BTMD

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: